Nexentis subsidiary achieves drug discovery milestone

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/28/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. ULTA
8. NVDA
9. GAP
10. DG

Go back to Nexentis subsidiary achieves drug discovery milestone
(NASDAQ: NXTS) Delayed: 1.84 -0.07 (3.66%)
Previous Close $1.91    52 Week High $ 
Open $1.89    52 Week Low $ 
Day High $2.05    P/E N/A 
Day Low $1.75    EPS $ 
Volume 77,971